• HIPAA Training for Laboratories: HIPAA Training for Laboratories is the same core HIPAA training…continue reading →
  • HIPAA Training for Clinical Trials: HIPAA Training for Clinical Trials is designed to help research…continue reading →
  • HIPAA Training for Clinical Research Staff: HIPAA Training for Clinical Research Staff is designed to ensure…continue reading →

BioMed Advances

Groundbreaking discoveries and inventions in the Life Sciences advancing Evidence Based Medicine

  • Latest News
  • Biotechnology News
  • Disease Research News
  • Diagnostics News
  • Biomedical Discoveries
  • Featured Articles
    • CRISPR-Cas9 and Genome Editing
    • Degenerative Diseases

Disease Research News

Artificial Pancreas Improves Glycemic Control in Patients with Type 2 Diabetes

Artificial Pancreas Improves Glycemic Control in Patients with Type 2 Diabetes

  • 29th December 2018
  • Disease Research News
  • 0 Comments

An artificial pancreas or closed-loop insulin delivery system has been shown to be effective at controlling glucose levels in patients with type 1 diabetes, although the effectiveness of an artificial…

First European CRISPR Trial Commences

First European CRISPR Trial Commences

  • 14th November 2018
  • Disease Research News
  • 0 Comments

The first European CRISPR trial has commenced. Researchers will be investigating whether cells modified by CRISPR can produce more hemoglobin and alleviate the symptoms of beta-thalassemia. According to the U.S….

Parkinson’s Disease Stem Cell Treatment Trial Underway

Parkinson’s Disease Stem Cell Treatment Trial Underway

  • 13th November 2018
  • Disease Research News
  • 0 Comments

A clinical trial of an experimental treatment for Parkinson’s disease has commenced at Kyoto University Hospital in Japan. The trial is investigating whether stem cells injected into the brains of…

New CRISPR Enzyme Offers Greater Potential for Genome Editing

New CRISPR Enzyme Offers Greater Potential for Genome Editing

  • 26th October 2018
  • Disease Research News
  • 0 Comments

The CRISPR-Cas9 gene editing tool offers tremendous potential for treating diseases caused by genetic mutations. The system uses a short sequence of RNA, called guide RNA (gRNA), to identify a…

CRISPR Used to Cure Congenital Metabolic Disorders in Mice

CRISPR Used to Cure Congenital Metabolic Disorders in Mice

  • 12th October 2018
  • Disease Research News
  • 0 Comments

Two teams of researchers have successfully used CRISPR to correct genetic abnormalities that cause the inherited diseases phenylketonuria (PKU) and hereditary tyrosinemia type 1 (HT1). In both studies the researchers…

Potential Triple-Negative Breast Cancer Treatment Identified

Potential Triple-Negative Breast Cancer Treatment Identified

  • 10th October 2018
  • Disease Research News
  • 0 Comments

Research conducted in the UK and Spain suggests the diphenylbutylpiperidine class anti-psychotic drug Pimozide could potentially be used as a new treatment for triple-negative breast cancer after it was shown…

8,000 Drug Combinations More Effective Than Sum of Component Parts

8,000 Drug Combinations More Effective Than Sum of Component Parts

  • 10th September 2018
  • Disease Research News
  • 0 Comments

Treatment of infections of extensively drug-resistant bacteria is now a major challenge and the problem is getting worse. There are fears that healthcare may soon be returned to the era…

CRISPR Gene Editing Tool Used to Halt Muscular Dystrophy Progression in Dogs

CRISPR Gene Editing Tool Used to Halt Muscular Dystrophy Progression in Dogs

  • 4th September 2018
  • Disease Research News
  • 0 Comments

A landmark CRISPR gene editing study has been conducted on dogs with Duchenne Muscular Dystrophy by researchers at UT Southwestern’s Hamon Center for Regenerative Science and Medicine. The researchers have…

Drug Confirmed to Reduce Brain Shrinkage in Patients with Progressive Multiple Sclerosis

Drug Confirmed to Reduce Brain Shrinkage in Patients with Progressive Multiple Sclerosis

  • 30th August 2018
  • Disease Research News
  • 0 Comments

A recent clinical trial has confirmed the drug Ibudilast reduces brain shrinkage in patients with progressive multiple sclerosis. Multiple sclerosis is a condition affecting the brain and spinal cord. The…

New Technique Allows Researchers to Grow Human Astrocytes in Just Two Weeks

New Technique Allows Researchers to Grow Human Astrocytes in Just Two Weeks

  • 23rd August 2018
  • Disease Research News
  • 0 Comments

Functional brain cells – astrocytes – play an important role in normal brain function. The star-shaped glial cells are also known to play a role in the development of neurodegenerative…

  • 1
  • …
  • 11
  • 12
  • 13
  • 14
  • 15
  • …
  • 20

CRISPR-Cas9
Article Series

  • Introduction to CRISPR-Cas9 and Genome Editing
  • CRISPR-Cas9 in Disease Control
  • CRISPR-Cas9 and Human Health
  • CRISPR-Cas9 Agricultural Applications
  • Modulating Gene Expression: CRISPRi
  • CRISPR-Cas9: A New Way to Edit RNA
  • Disease Modelling with CRISPR-Cas9
  • CRISPR-Cas9 Regulation
  • Future of CRISPR-Cas9 Technology

Degenerative Disease Articles

  • Alzheimer’s Disease: Pathology and Causes
  • Alzheimer’s Disease: Current and Prospective Research
  • Parkinson’s Disease: Pathology and Causes
  • Current and Future Treatments for Parkinson’s Disease
  • Motor Neuron Disease
  • Huntington’s Disease
Free Weekly Newsletter

Free Service

Confidentiality Guaranteed

Email address never shared,
unsubscribe any time

© BioMed Advances     Site Map